00
Kelun Pharma
002422.SZ·SZSEChengdu CNFounded 199616,000 employees
Mid CappharmaPublicOncologyInfectious Disease
Platform: Large Infusion
Market Cap
$6B
All Drugs
4
Clinical Trials
8
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (002422.SZ)
Loading 002422.SZ stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Ribotapinarof | 002-2538 | Phase 2 | 1 | WRN | FSGS | ||
| 002-6973 | 002-6973 | Approved | 4 | MET | RCCNSCLC | ||
| 002-2150 | 002-2150 | Phase 2 | 1 | GIP-R | CFCML | ||
| 002-8467 | 002-8467 | Phase 1/2 | 2 | SHP2 | Ewing SarcomaEpilepsy |
SEC Filings & Financial Documents
SEC filings are not available for SZSE-listed companies.
Kelun Pharma trades on SZSE (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (8)